Cluster headaches are widely recognized as one of the most painful conditions a person can experience, often described as sharper and more intense than childbirth or kidney stones. The attacks strike suddenly, usually centered around one eye, and can occur multiple times a day for weeks or months. This cycle can be devastating, disrupting sleep, work, and relationships, leaving patients exhausted and anxious about the next onset. 

Effective treatment is vital not just for pain relief, but for restoring a sense of control over daily life. Because the attacks escalate rapidly often reaching peak intensity within minutes, standard oral painkillers usually work too slowly to be helpful. Therefore, the medical approach is specialized, focusing on stopping attacks immediately and breaking the cycle of recurrence. Treatment plans are highly individualized, often requiring a combination of fast-acting therapies and daily preventative medications (American Migraine Foundation, 2023). 

Overview of treatment options for Cluster Headache 

The management of cluster headaches is divided into two distinct categories: abortive (acute) treatment and preventative treatment. Abortive treatments aim to stop a headache that has already started. Because these headaches are short but severe, these medications must be administered via routes that enter the bloodstream quickly, such as injections or inhalation, rather than pills. 

Preventative treatments are taken daily, regardless of whether a headache is present. The goal is to reduce the frequency and severity of the attacks and eventually end the cluster cycle. For many patients, a “bridge” therapy is also used to provide temporary relief while the long-term preventative medications build up in the system. 

Medications used for Cluster Headache 

For acute (abortive) treatment, high-flow oxygen therapy is a standard first-line option. Inhaling 100% oxygen through a non-rebreather mask for 15 minutes can abort an attack for many patients without medication side effects. Clinical experience suggests that this is effective for approximately 70% of patients if used correctly at the onset of pain. 

The other primary abortive options are triptans. Injectable sumatriptan is the most effective medical treatment because it works quickly. Nasal sprays (such as zolmitriptan or sumatriptan) are alternatives for those who cannot tolerate injections, though they take slightly longer to work. 

For preventative treatment, calcium channel blockers are the most common first-line choice. Verapamil is frequently prescribed at higher doses than what is used for heart conditions. 

If verapamil is ineffective, doctors may prescribe lithium carbonate, particularly for chronic cluster headaches. Corticosteroids, such as prednisone, are often used as a short-term “bridge” therapy to suppress the cycle quickly while waiting for other drugs to take effect. Recently, galcanezumab, a CGRP monoclonal antibody injection, was approved specifically for reducing the frequency of episodic cluster headache attacks (Mayo Clinic, 2022). 

How these medications work 

Oxygen therapy is believed to work by causing vasoconstriction (narrowing) of the blood vessels in the brain, which are dilated during an attack. It also likely inhibits the neuronal activation in the trigeminal nerve system responsible for the pain. 

Triptans mimic the action of serotonin, a brain chemical. They bind to specific receptors to constrict blood vessels and block pain pathways in the brainstem. 

Preventative drugs like verapamil work by relaxing blood vessels and, more importantly, stabilizing the electrical activity of cells in the hypothalamus, the part of the brain often cited as the “clock” that regulates the timing of cluster cycles. Galcanezumab works differently by blocking a specific protein (CGRP) that spikes during headache attacks and transmits pain signals (National Institute of Neurological Disorders and Stroke, 2023). 

Side effects and safety considerations 

Oxygen therapy is generally safe, though it requires carrying a tank. Triptans, because they constrict blood vessels, are generally not recommended for patients with a history of heart disease, stroke, or uncontrolled high blood pressure. Patients may experience chest tightness or tingling after use. 

Preventative medications require monitoring. Verapamil can cause low blood pressure, constipation, and fluid retention; doctors often perform EKGs to monitor heart rhythm. Lithium requires regular blood tests to check kidney and thyroid function, as the therapeutic window is narrow. Corticosteroids can cause insomnia, mood swings, and elevated blood sugar, so they are strictly limited to short-term use. 

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care. 

References 

  1. American Migraine Foundation. https://americanmigrainefoundation.org 
  1. Mayo Clinic. https://www.mayoclinic.org 
  1. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov 
  1. Cleveland Clinic. https://my.clevelandclinic.org 

Medications for Cluster Headache

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Cluster Headache.

Found 9 Approved Drugs for Cluster Headache

SUMAtriptan

Brand Names
Migranow, Zembrace SymTouch, Onzetra Xsail, Tosymra, Imitrex, Treximet

SUMAtriptan

Brand Names
Migranow, Zembrace SymTouch, Onzetra Xsail, Tosymra, Imitrex, Treximet
IMITREX injection is indicated in adults for the acute treatment of migraine, with or without aura, and the acute treatment of cluster headache. Limitations of Use: Use only if a clear diagnosis of migraine or cluster headache has been established. If a patient has no response to the first migraine or cluster headache attack treated with IMITREX injection, reconsider the diagnosis before IMITREX injection is administered to treat any subsequent attacks., IMITREX injection is not indicated for the prevention of migraine or cluster headache attacks. IMITREX injection is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for:, Acute treatment of migraine with or without aura in adults ( 1 ), Acute treatment of cluster headache in adults ( 1 ) Limitations of Use:, Use only if a clear diagnosis of migraine or cluster headache has been established ( 1 ), Not indicated for the prophylactic therapy of migraine or cluster headache attacks ( 1 )

Zolmitriptan

Brand Names
Zolmiptriptan, ZOMIG

Zolmitriptan

Brand Names
Zolmiptriptan, ZOMIG
Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. Zolmitriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. Zolmitriptan tablets are a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults Limitations of Use: Use only after a clear diagnosis of migraine has been established Not indicated for the prophylactic therapy of migraine Not indicated for the treatment of cluster headache.

Naratriptan

Generic Name
Naratriptan

Naratriptan

Generic Name
Naratriptan
Naratriptan is indicated for the acute treatment of migraine attacks with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with naratriptan, reconsider the diagnosis of migraine before naratriptan is administered to treat any subsequent attacks., Naratriptan is not indicated for the prevention of migraine attacks., Safety and effectiveness of naratriptan have not been established for cluster headache. Naratriptan is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use:, Use only if a clear diagnosis of migraine has been established. ( 1 ), Not indicated for the prophylactic therapy of migraine attacks. ( 1 ), Not indicated for the treatment of cluster headache. ( 1 )

FROVA

Generic Name
Frovatriptan

FROVA

Generic Name
Frovatriptan
Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Use only if a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with frovatriptan succinate tablets, reconsider the diagnosis of migraine before frovatriptan succinate tablets are administered to treat any subsequent attacks. Frovatriptan succinate tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of frovatriptan succinate tablets have not been established for cluster headache. Frovatriptan succinate is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use Use only after a clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 )

Rizatriptan

Brand Names
Maxalt-Mlt, Maxalt

Rizatriptan

Brand Names
Maxalt-Mlt, Maxalt
Rizatriptan benzoate orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use Rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate orally disintegrating tablets are administered to treat any subsequent attacks., Rizatriptan benzoate orally disintegrating tablets are not indicated for use in the management of hemiplegic or basilar migraine., Rizatriptan benzoate orally disintegrating tablets are not indicated for the prevention of migraine attacks., Safety and effectiveness of rizatriptan benzoate orally disintegrating tablets have not been established for cluster headache. Rizatriptan benzoate is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age ( 1 ) Limitations of Use:, Use only after clear diagnosis of migraine has been established ( 1 ), Not indicated for the prophylactic therapy of migraine ( 1 ), Not indicated for the treatment of cluster headache ( 1 )
Showing 1-5 of 9
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances